Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dausse LabfiledCriticalDausse Lab
Application grantedgrantedCritical
Publication of AT247319BpublicationCriticalpatent/AT247319B/de
C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D263/48—Nitrogen atoms not forming part of a nitro radical
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
AT180564A1963-03-011964-03-02Verfahren zur Herstellung des neuen 5-Phenyl-2-cyclopropylamino-4-oxazolinons
AT247319B
(de)